|
Post by kite on Oct 29, 2021 9:42:03 GMT -5
investors.mannkindcorp.com/sec-filings/sec-filing/ct-order/9999999997-21-005594ORDER GRANTING CONFIDENTIAL TREATMENT UNDER THE SECURITIES EXCHANGE ACT OF 1934 MannKind Corporation File No. 0-50865 - CF# 36895 MannKind Corporation submitted an application under Rule 24b-2 requesting an extension of a previous grant of confidential treatment for information it excluded from the Exhibits to a Form 10-Q filed on November 1, 2018. Based on representations by MannKind Corporation that this information qualifies as confidential commercial or financial information under the Freedom of Information Act, 5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly disclose it. Accordingly, excluded information from the following exhibit(s) will not be released to the public for the time period(s) specified: Exhibit 10.8 through November 1, 2024 Exhibit 10.9 through November 1, 2024 For the Commission, by the Division of Corporation Finance, pursuant to delegated authority: Robert Errett Chief, Disclosure Management Office
|
|
|
Post by goyocafe on Oct 29, 2021 11:19:12 GMT -5
Ah, more transparency, just what the doctor ordered.
|
|
|
Post by peppy on Oct 29, 2021 11:50:47 GMT -5
The shroud of mystery.
|
|
|
Post by kite on Oct 29, 2021 15:06:47 GMT -5
|
|
|
Post by Clement on Oct 29, 2021 15:11:24 GMT -5
Is this concerning the deal with uthr which was about that time?
"extension of a previous grant of confidential treatment for information it excluded from the Exhibits to a Form 10-Q filed on November 1, 2018."
|
|
|
Post by lennymnkd on Oct 29, 2021 15:56:17 GMT -5
Is this concerning the deal with uthr which was about that time? "extension of a previous grant of confidential treatment for information it excluded from the Exhibits to a Form 10-Q filed on November 1, 2018." Is this the undisclosed molecule?
|
|
|
Post by afrezzamiracle on Oct 30, 2021 1:58:03 GMT -5
Perhaps this is a trade secret related to the use of Bluehale to shield our technology advances from competitors?
|
|
|
Post by cjm18 on Oct 30, 2021 7:54:12 GMT -5
Keven mik on ST thinks the secret Info is what mannkind did to get the 50m in milestones and 10m in research.
|
|
|
Post by dh4mizzou on Oct 30, 2021 9:36:12 GMT -5
Curious. How long can this hide and seek game go on?
|
|
|
Post by sportsrancho on Oct 30, 2021 9:46:08 GMT -5
Curious. How long can this hide and seek game go on? I remember another one of these way back and it was about the Sanofi settlement or agreement.
|
|
|
Post by prcgorman2 on Oct 30, 2021 15:39:17 GMT -5
Just looks like a perfunctory 3 year extension of whatever was made confidential 3 years ago.
|
|
|
Post by olderteampt on Oct 30, 2021 19:36:46 GMT -5
I remember a similar confidential agreement with Sanofi also and we all know how well that worked out for MNKD shareholders.
|
|
|
Post by BD on Oct 30, 2021 21:04:34 GMT -5
I remember a similar confidential agreement with Sanofi also and we all know how well that worked out for MNKD shareholders. Things changed at the top at Sanofi between the time that agreement would have been made and the time the wheels came off the bus. I think top-level management at UTHR is probably a bit more stable.
|
|
|
Post by prcgorman2 on Oct 31, 2021 0:59:52 GMT -5
I remember a similar confidential agreement with Sanofi also and we all know how well that worked out for MNKD shareholders. Step up your game. If it was confidential, how would you remember it? And since this is confidential, how do you know it’s similar? Good grief.
|
|
|
Post by sportsrancho on Oct 31, 2021 5:38:46 GMT -5
I believe the confidential one with Sanofi is still intact too because they extended that one twice.
|
|